Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats

Life Sci. 2004 Dec 3;76(3):319-29. doi: 10.1016/j.lfs.2004.08.011.

Abstract

The use of local anesthetics, such as lidocaine, has been proposed in the treatment of distal ulcerative colitis. Trimebutine maleate (TMB) displays a local anesthetic activity higher than that of lidocaine in rabbit corneal reflex. TMB and nor-TMB its main metabolite in human show similar affinity to that of bupivacaine toward sodium channel labeled by [3H]batrachotoxin and block sodium currents in sensory neurons from rat dorsal root ganglia. The aim of this study was to evaluate the effects of TMB and nor-TMB in comparison to lidocaine and bupivacaine in a rat model of acute colonic inflammation induced by trinitrobenzene sulfonic acid (TNBS). A single intracolonic instillation of TNBS (50 mg/kg dissolved in ethanol 30%) led to early plasma extravasation then macroscopic damage (hyperemia and necrosis), increased colonic weight and tissular MPO, a marker of neutrophilic infiltration. Local administration of TMB at dose of 3 to 60 mg/kg, 30 min before, 24 and 48 h after colitis induction, significantly reduced the severity of colitis. Nor-TMB (1, 3, 10, 30 mg/kg) as well as lidocaine (1, 3, 10 mg/kg) dose-dependently reduced colitis while bupivacaine at 10 mg/kg did not affect it significantly. In contrast systemic administration of TMB, nor-TMB and lidocaine at 10 mg/kg had no significant effect. Furthermore, local administration of TMB (30 mg/kg) and lidocaine (10 mg/kg) significantly reduced plasmatic extravasation. In conclusion, intracolonic treatment with TMB and nor-TMB improved acute experimental TNBS-induced colitis in rat and these effects could be explained by their local anesthetic activity.

MeSH terms

  • Administration, Rectal
  • Anesthetics, Local / therapeutic use*
  • Animals
  • Bupivacaine / administration & dosage
  • Bupivacaine / therapeutic use
  • Colitis / chemically induced
  • Colitis / drug therapy*
  • Colitis / pathology
  • Colon / drug effects
  • Colon / pathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Injections, Subcutaneous
  • Lidocaine / administration & dosage
  • Lidocaine / therapeutic use
  • Male
  • Organ Size / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Trimebutine / administration & dosage
  • Trimebutine / analogs & derivatives*
  • Trimebutine / therapeutic use*
  • Trinitrobenzenesulfonic Acid / toxicity

Substances

  • Anesthetics, Local
  • Gastrointestinal Agents
  • N-desmethyltrimebutine
  • Trinitrobenzenesulfonic Acid
  • Lidocaine
  • Trimebutine
  • Bupivacaine